Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA foretinib CTRPv2 pan-cancer AAC -0.019 0.6
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA SCH-529074 CTRPv2 pan-cancer AAC -0.02 0.6
mRNA TGX221 GDSC1000 pan-cancer AAC -0.024 0.6
mRNA NSC-207895 GDSC1000 pan-cancer AAC -0.017 0.6
mRNA BMS-195614 CTRPv2 pan-cancer AAC 0.019 0.6
mRNA AZD8055 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA Ko-143 CTRPv2 pan-cancer AAC 0.019 0.6
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
Download CSV